NPPNY
Price:
$6.75
Market Cap:
$269.37B
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Switzerland, and internationally. The company operates through Pharmaceuticals and Functional Food segments. It offers drugs for urological diseases, inflammation and allergies, hematologic malignancies, cardiovascular and metabolic diseases, gastrointestinal disorders, and other diseases. The company's products include Zalutia for urinary disorder caused by benign prostatic; Eviprostat for prostatic hypertrophy; Bladderon for pollakisuria; Estracyt for prostate cancer; Cialis for erectile dysfunction; Vidaza for myelodysplastic syndrome; Cylocide for solid tumor and acute leukemia; CylocideN for relaps...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2016-11-16
Stock Exchange
PNK
Ticker
NPPNY
According to Nippon Shinyaku Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 12.53%. This represents a change of 300.53% compared to the average of 3.13% of the last 4 quarters.
The mean historical ROE of Nippon Shinyaku Co., Ltd. over the last ten years is 10.56%. The current 12.53% ROE has changed 18.64% with respect to the historical average. Over the past ten years (40 quarters), NPPNY's ROE was at its highest in in the December 2016 quarter at 7.65%. The ROE was at its lowest in in the March 2017 quarter at -1.34%.
Average
10.56%
Median
11.63%
Minimum
5.82%
Maximum
13.84%
Discovering the peaks and valleys of Nippon Shinyaku Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 66.57%
Maximum Annual ROE = 13.84%
Minimum Annual Increase = -15.72%
Minimum Annual ROE = 5.82%
Year | ROE | Change |
---|---|---|
2024 | 11.74% | 0.66% |
2023 | 11.66% | -15.72% |
2022 | 13.84% | 14.89% |
2021 | 12.04% | 3.89% |
2020 | 11.59% | -4.05% |
2019 | 12.08% | 17.01% |
2018 | 10.33% | 0.27% |
2017 | 10.30% | 66.57% |
2016 | 6.18% | 6.16% |
2015 | 5.82% | -5.82% |
The current ROE of Nippon Shinyaku Co., Ltd. (NPPNY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.41%
5-year avg
12.17%
10-year avg
10.56%
Nippon Shinyaku Co., Ltd.’s ROE is less than Genomma Lab Internacional, S.A.B. de C.V. (2.60%), less than City View Green Holdings Inc. (65.45%), greater than Procyon Corporation (-14.39%), greater than West Island Brands Inc. (0%), greater than The BC Bud Corporation (-383.06%), less than Hypera S.A. (13.22%), greater than Sumitomo Pharma Co., Ltd. (-97.03%), less than Indivior PLC (4.23%), greater than YourWay Cannabis Brands Inc. (0%), greater than Cumberland Pharmaceuticals Inc. (-40.17%), less than Amexdrug Corporation (4.42%), less than Aion Therapeutic Inc. (304.86%), less than Aspen Pharmacare Holdings Limited (0.44%), greater than Antisense Therapeutics Limited (-109.43%), greater than Alterola Biotech, Inc. (-20.20%), less than Molecule Holdings Inc. (297.34%), greater than BZAM Ltd. (-80.01%), greater than Curaleaf Holdings, Inc. (-20.19%), greater than Aurora Cannabis Inc. (-118.26%), greater than Canopy Growth Corporation (-108.18%),
Company | ROE | Market cap |
---|---|---|
2.60% | $1.30B | |
65.45% | $3.75M | |
-14.39% | $1.63M | |
0% | $4.91B | |
-383.06% | $3.31M | |
13.22% | $2.17B | |
-97.03% | $1.51B | |
4.23% | $2.89B | |
0% | $17.82M | |
-40.17% | $14.88M | |
4.42% | $338.82K | |
304.86% | $5.08M | |
0.44% | $5.44B | |
-109.43% | $19.64M | |
-20.20% | $5.84M | |
297.34% | $244.46K | |
-80.01% | $2.71K | |
-20.19% | $1.47B | |
-118.26% | $238.17M | |
-108.18% | $498.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nippon Shinyaku Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nippon Shinyaku Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Nippon Shinyaku Co., Ltd.'s ROE?
How is the ROE calculated for Nippon Shinyaku Co., Ltd. (NPPNY)?
What is the highest ROE for Nippon Shinyaku Co., Ltd. (NPPNY)?
What is the 3-year average ROE for Nippon Shinyaku Co., Ltd. (NPPNY)?
What is the 5-year average ROE for Nippon Shinyaku Co., Ltd. (NPPNY)?
How does the current ROE for Nippon Shinyaku Co., Ltd. (NPPNY) compare to its historical average?